Naftopidil
Thông số
57149-07-2Số CAS
692-531-5Số EC
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-olTên IUPAC
C24H28N2O3Công thức hóa học
392.5 g/molKhối lượng phân tử
naftopidil; 57149-07-2; Flivas; Naftopidilum; DTXSID5045176; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; R9PHW59SFN; NSC-759293; DTXCID3025176; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol; 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 1-[4-(2-Methoxyphenyl)-1-piperazinyl]-3-(1-naphthyloxy)-2-propanol; RefChem:831691; (2RS)-1-(4-(2-Methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; Avishot; Naftopidil [INN]; KT-611; 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; (+/-)-Naftopidil; MFCD00242741; BM-15275; CHEMBL142635; NCGC00015718-06; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol; Naftopidilum [Latin]; SMR000466346; CAS-57149-07-2; UNII-R9PHW59SFN; BRN 0629965; Avishot;; Flivas (TN); Naftopidil (Standard); NAFTOPIDIL [MI]; NAFTOPIDIL [JAN]; Prestwick0_000975; Prestwick1_000975; Prestwick2_000975; Prestwick3_000975; (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol; Naftopidil (JP18/INN); (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol; cid_4418; NAFTOPIDIL [MART.]; NAFTOPIDIL [WHO-DD]; Lopac0_000941; REGID_for_CID_4418; BSPBio_001009; MLS000759459; MLS001424117; orb134855; SCHEMBL113215; SPBio_002920; BPBio1_001111; Naftopidil - Bio-X trade mark; orb1224628; orb1310376; SCHEMBL29449978; BDBM50773; CHEBI:31891; cid_6603044; HY-B0391R; HMS2051B09; HMS2089G07; HMS3393B09; HMS3655H21; HMS3884P07; HMS5080K14; Pharmakon1600-01506024; HY-B0391; Tox21_110205; EBC-03851; MFCD11046013; MSK163437; NSC759293; s2126; STL372645; (+-)-4-(o-Methoxyphenyl)-alpha-((1-naphthyloxy)methyl)-1-piperazineethanol; 1-Pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-; AKOS002279617; AKOS016328058; Tox21_110205_1; CCG-100935; CCG-205022; DB12092; FE-0209; FN26123; NC00185; NSC 759293; SB19321; SDCCGSBI-0050915.P003; NCGC00015718-04; NCGC00015718-05; NCGC00015718-08; NCGC00015718-09; NCGC00015718-10; NCGC00015718-12; NCGC00015718-22; NCGC00015718-25; NCGC00024672-03; NCGC00024672-04; BN164631; SY053735; SBI-0050915.P002; AB00514643; N0123; N0832; ST50794017; SW196570-4; T0696; D01674; AB00489961-18; AB00489961-19; AB00489961_20; AB00489961_21; EN300-6492981; F463444; Q6958243; BRD-A01787639-001-06-4; BRD-A01787639-001-07-2; BRD-A01787639-001-08-0; BRD-A01787639-003-16-9; BRD-A01787639-300-03-7; BRD-A01787639-300-04-5; BRD-A01787639-300-08-6; BRD-A01787639-300-09-4; Z31369389; 1-[4-(2-methoxyphenyl)piperazinyl]-3-naphthyloxypropan-2-ol; 1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol; 1-[4-(2-methoxyphenyl)piperazino]-3-(1-naphthoxy)propan-2-ol;hydrochloride; 4-(2-Methoxyphenyl)-?-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; (+/-)-4-(O-METHOXYPHENYL)-.ALPHA.-((1-NAPHTHYLOXY)METHYL)-1-PIPERAZINEETHANOL; 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthalenyloxy)-2-propanol;hydrochloride; 1-[4-(2-Methoxyphenyl)piperazin-1-yl]-3-[(naphthalen-1-yl)oxy]propan-2-ol; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxy-propan-2-ol;hydrochloride; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;hydrochloride; 4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol hydrochloride hydrateTên gọi khác
Sản phẩm chứa Naftopidil
나프토엠정75밀리그램(나프토피딜)일성나프토피딜정75밀리그램나포피딜정75밀리그램(나프토피딜)플로리스정(나프토피딜)플리스반정75밀리그램(나프토피딜)나스타정50밀리그램(나프토피딜)플리탑정75밀리그램(나프토피딜)(수출용)오스나프토정75mg(나프토피딜)(수출용)유니바스정75mg(나프토피딜)나스타정75밀리그램(나프토피딜)나프바스정75mg(나프토피딜)유로피딜정75밀리그램(나프토피딜)
Trang 1/4
Công ty đang bán Naftopidil
(주
(주)동구바이오제약Republic of Korea동국
동국제약(주)Republic of Korea아주
아주약품(주)Republic of Korea동아
동아에스티(주)Republic of Korea일성
일성아이에스(주)Republic of Korea日医
日医工株式会社Japan東和
東和薬品株式会社Japan沢井
沢井製薬株式会社Japan한국
한국코러스(주)Republic of Koreaニプ
ニプロ株式会社Japan(주
(주)마더스제약Republic of KoreaTrang 1/3